Karen S. Canady, Partner
Karen Canady is a founding partner of Canady + Lortz LLP, where her practice focuses on biotechnology patent preparation and prosecution, client counseling, patent clearances and opinion work, and due diligence.
Some examples of her work include developing and prosecuting a patent portfolio on lentiviral gene delivery, which was sold for $12 million, and evaluating a patent portfolio of antisense molecules to help a client close a licensing deal for an upfront fee of $45 million with potential for over $230 million in milestone payments.
Dr. Canady has a JD from University of Washington School of Law, a PhD in Behavioral Neuroscience from University of Washington, and a Bachelor of Science degree from Pacific University. While a law student, she worked part-time at the University of Washington technology transfer office, then at a Seattle intellectual property firm.
She spent her first year after law school as a trainee with a European patent firm in Munich. After spending the next two-and-a-half years at a mid-size intellectual property firm, she founded the biotechnology practice group at a small Los Angeles boutique firm, and in 2006, merged her practice with Origin Law to form Canady + Lortz LLP. |
Sanjesh Prabha Sharma, Moderator
Sanjesh Sharma is Senior Intellectual Property Counsel at Johnson & Johnson Surgical Vision, where she supports all aspects of intellectual property matters for the business’s laser refractive and cataract surgery product lines. She manages global patent portfolios, due diligence for acquisitions and transactions, freedom to operate clearances for product development, as well as any litigation and related inter partes proceedings in the U.S. and opposition/nullity actions in Europe. Sanjesh is the current Chair of the IP Law Section and the Patent Interest Group.
Adding Registration, Please wait...
